Jazz Pharmaceuticals JAZZ Non-voting euro deferred shares
Non-voting euro deferred shares at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:NonvotingEuroDeferredShares.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's non-voting euro deferred shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's non-voting euro deferred shares?
- Jazz Pharmaceuticals (JAZZ) reported non-voting euro deferred shares of $100K in Q1 2026.
- How has Jazz Pharmaceuticals's non-voting euro deferred shares changed year-over-year?
- Jazz Pharmaceuticals's non-voting euro deferred shares increased by 81.8% year-over-year, from $55K to $100K.
- What is the long-term trend for Jazz Pharmaceuticals's non-voting euro deferred shares?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's non-voting euro deferred shares has grown at a 12.7% compound annual growth rate (CAGR), from $55K to $100K.
- What does non-voting euro deferred shares mean?
- Non-voting shares with no real economic value, often used for legal or structural compliance.
- How do you interpret non-voting euro deferred shares?
- Changes in this metric are usually related to corporate legal restructuring rather than operational performance.
- How does non-voting euro deferred shares compare across companies?
- Specific to companies incorporated in jurisdictions like Ireland; rarely seen in US-only domestic corporations.